Is Royalty Pharma plc (RPRX) a Warren Buffett Stock?
Partial Buffett fit - meets 4/9 key criteria, but with reservations.
4/9 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 58 → lifted to 66 before grade derivation.
Capped from B to C. EPS dropped more than 50% at the worst point in the last 5 years - cyclical or fragile What are deal-breaker caps?
Warren Buffett's Criteria, Applied to RPRX
ROIC ≥ 15%
Gross margin ≥ 40%
Owner earnings yield ≥ 5%
5y profitable
Net Debt / EBITDA ≤ 3
Revenue CAGR ≥ 8%
EPS CAGR ≥ 8%
FCF / Net income ≥ 0.8
Debt / Equity ≤ 1
How RPRX Scores on Other Strategies
Live Financial Snapshot
Market cap
$32.43B
P/E (TTM)
27.6x
ROIC (TTM)
8.43%
Gross margin
99.95%
Other Warren Buffett fit reports
Frequently Asked Questions
What is RPRX's Warren Buffett fit score?
Does Warren Buffett actually own RPRX?
How often is this score updated?
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends RPRX.